P3H2 and breast cancer: However, mRNA analysis implies that down-regulation of P3H2 is associated with less favourable prognosis in some breast cancer series (van de Vijver et al, 2002; Pawitan et al, 2006; Desmedt et al, 2007) and recurrence after tamoxifen (Ma et al, 2004).